SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

x402jobs

x402jobs ($JOBS) is trending amid community excitement and speculation about its potential. Discussions center on its low market cap and revenue-sharing model, with many anticipating significant growth.

ARB IOT Group Ltd. is a holding company that engages in the provision of solutions for the integration of IoT systems and devices. It operates through the Internet of Things and Investment Holding and Others segments. The company was founded on March 1, 2022 and is headquartered in Singapore.

ARB IOT Group Ltd

ARBB is trending due to speculation around a potential short squeeze, fueled by its small float and analyst target prices. Community discussions compare it to past runners like $SMX, anticipating a similar explosive move. Traders are closely watching key price levels, particularly the $8 mark, as a breakout point for further upward momentum.

MP Materials Corp. engages in the production and marketing of rare earth specialty materials. It operates through the Materials and Magnetics segments. The Materials segment focuses on the operation of Mountain Pass, which produces refined rare earth oxides and related products, as well as rare earth concentrate products. The Magnetics segment is involved in the operation of Independence Facility, where the company began production of magnetic precursor products. The company was founded by James Henry Litinsky and Michael Rosenthal in 2017 and is headquartered in Las Vegas, NV.

MP Materials Corporation

MP is trending due to an Overweight upgrade from Morgan Stanley, citing the company's key role in the U.S. push for a domestic rare earth supply chain and a raised price target. Community discussions revolve around the potential benefits from U.S. efforts to reduce critical mineral dependence, with some highlighting strategic partnerships and government support, while others express concern about stock manipulation and await further catalysts.

Spruce Biosciences, Inc. is a biopharmaceutical company, which engages in developing and commercializing novel therapies for rare endocrine disorders with significant unmet medical need. The company was founded on November 13, 2014 and is headquartered in South San Francisco, CA.

Spruce Biosciences Inc

SPRB is trending due to community discussion around a recent financing announcement and its potential impact on the stock's future. Some traders are comparing SPRB's volatility and past performance to other low-float biotech stocks, while others discuss potential price targets and short squeeze opportunities. The community is also noting the involvement of a controversial figure, Martin Shkreli, and his potential influence on the stock.

Galectin Therapeutics, Inc. is a biotechnology company, which engages in drug research and development to create new therapies for fibrotic disease, severe skin disease, and cancer. Its programs target the development of carbohydrate molecules which offers alternative options to larger market segments. The company was founded by James C. Czirr and Anatole A. Klyosov on July 10, 2000 and is headquartered in Norcross, GA.

Galectin Therapeutics Inc

GALT is trending as community members discuss the potential for partnerships and buyout opportunities following promising trial data. The discussion is centered around the possibility of accelerated FDA approval and the potential for a significant buyout offer, with some speculating on the involvement of major pharmaceutical players. Community members are also referencing 

FibroGen, Inc. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of novel therapeutics. It focuses on the hypoxia-inducible factor and connective tissue growth factor biology to develop medicines for the treatment of anemia, fibrotic disease, and cancer. The company was founded by Thomas B. Neff on September 29, 1993, and is headquartered in San Francisco, CA.

FibroGen Inc

FibroGen is trending as the community discusses recent insider buying and the potential for a near-term catalyst from their oncology program. Chatter revolves around the company's financial position following the sale of its China operations and upcoming decisions regarding a reverse stock split. Community members are weighing the prospects for Roxadustat and the company's pipeline in the face of continued listing requirements.

BlackRock, Inc. engages in the provision of investment, advisory and risk management solutions. Its products include single-asset and multi-asset portfolios. The company was founded by Laurence Douglas Fink in 1988 and is headquartered in New York, NY.

Blackrock Inc.

BlackRock ($BLK) is trending due to a mix of technical analysis suggesting buying opportunities and analysts updating their ratings to overweight. Community discussions also revolve around BlackRock's potential moves in crypto, including tokenization and Bitcoin ETFs, influencing market sentiment. Additionally, a potential $38 billion deal for AES Corp is generating buzz.

ProShares Trust - ProShares Ultra VIX Short-Term Futures ETF

ProShares Ultra VIX Short-Term Futures ETF

UVXY is trending as traders assess its potential as a hedge against market volatility, especially with upcoming economic data releases and geopolitical concerns. The community is actively discussing entry and exit points, while also weighing the impact of contango and reverse splits on its long-term performance. Despite some skepticism about its leverage and decay, UVXY remains a focal point for those seeking to profit from short-term market swings.

Volatility Shares Trust - 2x Long VIX Futures ETF

Volatility Shares 2x Long VIX Futures ETF

UVIX is trending as traders discuss volatility hedging strategies amid market fluctuations and potential geopolitical risks. Community members are debating the effectiveness of UVIX as a hedge, especially with the VIX experiencing suppressed movement. Discussions also include potential market catalysts like upcoming Fed decisions and Japan's rate policy.

Plasma is the layer 1 blockchain building the stablecoin infrastructure for a new global financial system.   It is purpose-built for global stablecoin payments, offering zero-fee USD₮ transfers and custom gas tokens to help realise the stablecoin promise of permissionless access to financial services for everyone, everywhere.   Plasma’s global payments coverage and inbound suite of products position it as the native chain for stablecoin payments.

Plasma

Plasma (XPL) is seeing volatile discussion as traders debate whether it's reached a bottom after a significant price drop since launch. Sentiment is mixed, with some calling it a scam and others anticipating a recovery, pointing to its underlying technology and potential for real utility in stablecoin transfers. Community chatter also mentions a token unlock event, with some anticipating a potential negative impact on price.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Health In Tech Announces Voluntary Extension of Lock-Up Period

Health In Tech Announces Voluntary Extension of Lock-Up Period Health In Tech Announces Voluntary Extension of Lock-Up Period PR Newswire STUART, Fla., Dec. 2, 2025 STUART, Fla., Dec. 2, 2025...

Health In Tech (NASDAQ:HIT) Downgraded to "Hold" Rating by Wall Street Zen

Wall Street Zen lowered shares of Health In Tech from a "buy" rating to a "hold" rating in a research report on Sunday...

FY2025 EPS Estimates for Health In Tech Reduced by Analyst

Health In Tech, Inc. (NASDAQ:HIT - Free Report) - Zacks Small Cap reduced their FY2025 earnings per share (EPS) estimates for Health In Tech in a research note issued on Wednesday, November 12th...

Health In Tech (NASDAQ:HIT) Announces Earnings Results, Hits Estimates

Health In Tech (NASDAQ:HIT - Get Free Report) posted its earnings results on Monday. The company reported $0.01 EPS for the quarter, meeting analysts' consensus estimates of $0.01...

Health In Tech and AlphaTON Capital to Unveil Blockchain Healthcare Vision at Web Summit Lisbon

Health In Tech and AlphaTON Capital to Unveil Blockchain Healthcare Vision at Web Summit Lisbon Health In Tech and AlphaTON Capital to Unveil Blockchain Healthcare Vision at Web Summit Lisbon PR...

Health In Tech Announces Third Quarter 2025 Financial Results

Health In Tech Announces Third Quarter 2025 Financial Results Health In Tech Announces Third Quarter 2025 Financial Results PR Newswire STUART, Fla., Nov. 10, 2025 Revenue reached $8.5 million, up...

Health In Tech Announces New Davos 2026 Panel: "First Ladies: Backing Women Who Build" Featuring Cherie Blair CBE, KC

Health In Tech Announces New Davos 2026 Panel: 'First Ladies: Backing Women Who Build' Featuring Cherie Blair CBE, KC Health In Tech Announces New Davos 2026 Panel: 'First Ladies: Backing Women Who...

Health In Tech Showcases Enhanced eDIYBS Platform at SIIA 2025, Accelerating Broker Growth and Market Reach

Health In Tech Showcases Enhanced eDIYBS Platform at SIIA 2025, Accelerating Broker Growth and Market Reach Health In Tech Showcases Enhanced eDIYBS Platform at SIIA 2025, Accelerating Broker Growth...

Health in Tech, Inc. engages in the provision of insurance technology platforms which offer a marketplace of processes in the healthcare industry. Its services include Stone Mountain Risk, eDIYBS, HI Card, HI Performance Network, and Ancillary Products. The company was founded by Tim Johnson in 2014 and is headquartered in Stuart, FL.

Current Price	$1.06
Prev Close	$1.06
Open	$1.06
Dividend Yield	0.00%
50-Day Moving Average	$2.30
Beta	0.89
Avg. Volume	456,098.26
PE Ratio	42.23

52-Week High	$7.59
52-Week Low	$0.512
Market Capitalization	$60.32M
EPS (Annual)	$0.0123
Price to Book	3.49
Revenue Per Employee	$243,636.33
Enterprise Value/EBITDA	N/A

HIT
Health In Tech Inc. - Ordinary Shares - Class A

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest HIT News

HITHealth In Tech Inc. - Ordinary Shares - Class A